Ranibizumab Biosimilar, VEGF Monoclonal Antibody Fab

Additional Information:
| Ranibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab) Recombinant Humanized Monoclonal Antibody Fragment (Fab) generated from the same |The research grade Fab protein ranibizumab was produced in the ranibizumab biosimilar E.coli cell line. Specificity/Sensitivity: The Fab protein ranibizumab specifically binds to the human VEGF-A. Applications: Functional assay, neutralization. Form of Antibody: 0.2 uM filtered solution, pH 5.3, no stabilizers or preservatives. Endotoxin: Purity: >95% by SDS-|The Fab protein ranibizumab is shipped with ice |Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |Background The humanized anti-VEGF-A monoclonal antibody drug Bevacizumab (trade name Avastin, Genentech/Roche) is the first clinically available angiogenesis inhibitor in the United States. The humanized anti-VEGF-A monoclonal antibody fragment (Fab) Ranibizumab (trade name Lucentis, Genentech) is derived from the same |Bevacizumab Biosimilar (complete antibody produced in CHO) Syd Labs also provides the following research grade antibody biosimilar proteins: Bevacizumab Biosimilar, research grade (VEGF-A) Ranibizumab Biosimilar, research grade (VEGF-A, Fab produced in E. coli) Cetuximab Biosimilar, research grade (HER1, ErbB-1, EGFR) Panitumumab Biosimilar, research grade (HER1, ErbB-1, EGFR) Trastuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu) Pertuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu) Infliximab biosimilar, research grade (TNF alpha) Adalimumab biosimilar, research grade (TNF alpha) Rituximab biosimilar, research grade (CD20) Denosumab biosimilar, research grade (RANKL, RANK ligand, OPGL, TNFSF11, CD254, TRANCE, ODF) Palivizumab Biosimilar, research grade (RSV) Omalizumab biosimilar, research grade (IgE) Eculizumab biosimilar, research grade (C5)